Research has indicated that the NLRP3 inflammasome plays a pivotal role in the development of ED24 and that inhibiting the NLRP3 inflammasome-mediated NF-κB signaling pathway can significantly attenuate the inflammatory response in diabetic nephropathy.25 This evidence concerns the gene NFKB1 and diabetic kidney disease.